Amneal bolsters US manufacturing capacity with Apiject collaboration deal
Amneal Pharmaceuticals inked a collaboration deal with syringe maker Apiject that will see the New Jersey-based biopharma boost its production capacity in the U.S. as well as support its efforts to reshore drug manufacturing in the country.
Amneal Pharmaceuticals inked a collaboration deal with syringe maker Apiject that will see the New Jersey-based biopharma boost its production capacity in the U.S. as well as support its efforts to reshore drug manufacturing in the country.
